APPLICATION OF SINGLE WIRELESS HOLTER TO SIMULTANEOUS EMG, MMG AND EIM MEASUREMENT OF HUMAN MUSCLES ACTIVITY

This paper describes application and design of wireless holter with innovative functionality, used it in field of human muscle monitoring. In our experiments we monitored EMG (electromyography), MMG (mechanomyography) and EIM (electrical impedance myography) all by single device. It is first time when these all parameters were monitored simultaneously taking advantage of the holter device data output in order to find the signals interconnection. Our data were compared with normally used medical device and signal quality was verified

Topics in linear and nonlinear dispersive waves

The various singularities and instabilities which arise in the modulation theory of dispersive wavetrains are studied. Primary interest is in the theory of nonlinear waves, but a study of associated questions in linear theory provides background information and is of independent interest. The full modulation theory is developed in general terms. In the first approximation for slow modulations, the modulation equations are solved. In both the linear and nonlinear theories, singularities and regions of multivalued modulations are predicted. Higher order effects are considered to evaluate this first order theory. An improved approximation is presented which gives the true behavior in the singular regions. For the linear case, the end result can be interpreted as the overlap of elementary wavetrains. In the nonlinear case, it is found that a sufficiently strong nonlinearity prevents this overlap. Transition zones with a predictable structure replace the singular regions. For linear problems, exact solutions are found by Fourier integrals and other superposition techniques. These show the true behavior when breaking modulations are predicted. A numerical study is made for the anharmonic lattice to assess the nonlinear theory. This confirms the theoretical predictions of nonlinear group velocities, group splitting, and wavetrain instability, as well as higher order effects in the singular regions.</p

The impact of phosphodiesterase‐5 inhibition or angiotensin‐converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload

Abstract While phosphodiesterase‐5 inhibition (PED5i) may prevent hypertrophy and failure in pressure‐overloaded heart in an experimental model, the impact of PDE5i on volume‐overload (VO)‐induced hypertrophy is unknown. It is also unclear whether the hypertrophied right ventricle (RV) and left ventricle (LV) differ in their responsiveness to long‐term PDE5i and if this therapy affects renal function. The goal of this study was to elucidate the effect of PDE5i treatment in VO due to aorto‐caval fistula (ACF) and to compare PDE5i treatment with standard heart failure (HF) therapy with angiotensin‐converting enzyme inhibitor (ACEi). ACF/sham procedure was performed on male HanSD rats aged 8 weeks. ACF animals were randomized for PDE5i sildenafil, ACEi trandolapril, or placebo treatments. After 20 weeks, RV and LV function (echocardiography, pressure‐volume analysis), myocardial gene expression, and renal function were studied. Separate rat cohorts served for survival analysis. ACF led to biventricular eccentric hypertrophy (LV: +68%, RV: +145%), increased stroke work (LV: 3.6‐fold, RV: 6.7‐fold), and reduced load‐independent systolic function (PRSW, LV: −54%, RV: −51%). Both ACF ventricles exhibited upregulation of the genes of myocardial stress and glucose metabolism. ACEi but not PDE5i attenuated pulmonary congestion, LV remodeling, albuminuria, and improved survival (median survival in ACF/ACEi was 41 weeks vs. 35 weeks in ACF/placebo, p = .02). PDE5i increased cyclic guanosine monophosphate levels in the lungs, but not in the RV, LV, or kidney. PDE5i did not improve survival rate and cardiac and renal function in ACF rats, in contrast to ACEi. VO‐induced HF is not responsive to PDE5i therapy